Drug intelligence / Profile preview

eucalyptus tereticornis extract

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Topical, Inhalation
01

Overview

Eucalyptus tereticornis extract is a natural product derived from the leaves or bark of the Eucalyptus tereticornis tree, commonly known as the red gum tree. The extracts contain a variety of phytochemicals including tannins, alkaloids, saponins, glycosides, terpenoids (notably ursolic acid lactone), flavonoids, steroids, and phenols. These bioactive compounds contribute to its reported medicinal properties such as anti-inflammatory[5], antimicrobial[4], hypoglycemic/antidiabetic[3], hypolipidemic[3], anxiolytic[6], stimulant, anaesthetic and antiseptic effects[2]. Mechanistically, its anti-inflammatory activity is attributed to membrane stabilization and inhibition of protein denaturation; antimicrobial effects are due to broad-spectrum inhibition against pathogens; metabolic benefits are linked to increased glucose uptake and reduced inflammatory activity in vitro. The essential oil has also demonstrated strong larvicidal and mosquitocidal activities against Anopheles stephensi mosquitoes at high doses[1][7].

Other names
Eucalyptus tereticornis leaf extractEucalyptus tereticornis bark extractRed gum tree extract

Beyond the preview

Go deeper on eucalyptus tereticornis extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on eucalyptus tereticornis extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call